Regulatory role of phosphorylation of tumor suppressor Fhit protein
抑癌Fhit蛋白磷酸化的调节作用
基本信息
- 批准号:17590275
- 负责人:
- 金额:$ 2.01万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2005
- 资助国家:日本
- 起止时间:2005 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The fragile FHIT gene is among the first targets of DNA damage in preneoplastic lesions and recent studies have shown that Fhit protein is involved in surveillance of genome integrity and checkpoint response after genotoxin exposure. We studied that Fhit modulate the checkpoint response via regulation of phosphorylation at Y114 of Fhit protein. The response was regulated Atr kinase, and define the responsiveness of normal and cancer cells. Furthermore, Fhit-deficient hematopoietic cells, exposed to the genotoxin hydroquinone, are resistant to the suppression of stem cell in vitro colony formation observed with wild type hematopoietic cells. The present results indicate that reduced oxidative stress, coupled with efficient but error-prone DNA damage repair, allows unscheduled, long-term survival of genotoxin-exposed Fhit-deficient hematopoietic stem cells carrying deleterious mutations, suggesting the significance in the multistep carcinogenesis.
脆弱的 FHIT 基因是癌前病变中 DNA 损伤的首要目标之一,最近的研究表明,Fhit 蛋白参与基因毒素暴露后基因组完整性和检查点反应的监测。我们研究了 Fhit 通过调节 Fhit 蛋白 Y114 的磷酸化来调节检查点反应。该反应受到 Atr 激酶的调节,并定义正常细胞和癌细胞的反应性。此外,暴露于基因毒素氢醌的Fhit缺陷造血细胞对野生型造血细胞在体外观察到的干细胞集落形成的抑制具有抵抗力。目前的结果表明,氧化应激的减少,加上有效但容易出错的 DNA 损伤修复,使得暴露于基因毒素、携带有害突变的 Fhit 缺陷造血干细胞能够意外长期存活,这表明其在多步致癌过程中的重要性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The epidermal growth factor receptor gene sequence is highly conserved in primary gastric cancers
- DOI:10.1002/jso.20426
- 发表时间:2006-01-01
- 期刊:
- 影响因子:2.5
- 作者:Mimori, K;Nagahara, H;Mori, M
- 通讯作者:Mori, M
FHIT is up-regulated by inflammatory stimuli and inhibits prostaglandin E2-mediated cancer progression
- DOI:10.1158/0008-5472.can-05-2509
- 发表时间:2006-03-01
- 期刊:
- 影响因子:11.2
- 作者:Mimori, K;Ishii, H;Mori, M
- 通讯作者:Mori, M
Differentially expressed genes in endothelial differentiation.
- DOI:10.1089/dna.2005.24.432
- 发表时间:2005-07
- 期刊:
- 影响因子:3.1
- 作者:H. Ishii;K. Mimori;M. Mori;A. Vecchione
- 通讯作者:H. Ishii;K. Mimori;M. Mori;A. Vecchione
Histone deacetylase inhibitor depsipeptide (FK228) induces apoptosis in leukemic cells by facilitating mitochondrial translocation of Bax, which is enhanced by the proteasome inhibitor bortezomib.
组蛋白脱乙酰酶抑制剂 depsipeptide (FK228) 通过促进 Bax 的线粒体易位诱导白血病细胞凋亡,蛋白酶体抑制剂硼替佐米可增强这种易位。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Sutheesophon;K.
- 通讯作者:K.
Rad9 modulates the P21WAF1 pathway by direct association with p53.
- DOI:10.1186/1471-2199-8-37
- 发表时间:2007-05-21
- 期刊:
- 影响因子:0
- 作者:Ishikawa K;Ishii H;Murakumo Y;Mimori K;Kobayashi M;Yamamoto K;Mori M;Nishino H;Furukawa Y;Ichimura K
- 通讯作者:Ichimura K
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ISHII Hideshi其他文献
ISHII Hideshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ISHII Hideshi', 18)}}的其他基金
Maximum performance and practical application of cancer biomarkers by measuring RNA methylation of extracellular vesicles
通过测量细胞外囊泡的 RNA 甲基化来实现癌症生物标志物的最大性能和实际应用
- 批准号:
19K22658 - 财政年份:2019
- 资助金额:
$ 2.01万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
International collaborative research for liquid biopsy and precision medicine by microfluidic technologies to extracellular vesicles
利用微流控技术对细胞外囊泡进行液体活检和精准医疗的国际合作研究
- 批准号:
18KK0251 - 财政年份:2018
- 资助金额:
$ 2.01万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (B))
Foundation construction and clinical application of next-generation RNA biomarker
新一代RNA生物标志物的基础构建及临床应用
- 批准号:
17H04282 - 财政年份:2017
- 资助金额:
$ 2.01万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
New construction of in vivo reprogramming technology by modified microRNA
修饰microRNA体内重编程技术的新构建
- 批准号:
15K15496 - 财政年份:2015
- 资助金额:
$ 2.01万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
New construction of innovative drug discovery foundation technology for refractory gastrointestinal cancer targeting cancer metabolomics
靶向癌症代谢组学的难治性胃肠癌创新药物发现基础技术新构建
- 批准号:
26293303 - 财政年份:2014
- 资助金额:
$ 2.01万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Identification of novel inducing factors pancreatic beta cells by iPS modified technology
通过 iPS 修饰技术鉴定新型诱导因子胰腺 β 细胞
- 批准号:
25670556 - 财政年份:2013
- 资助金额:
$ 2.01万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Innovative therapeutic strategies: Cellular reprogramming of gastrointestinal cancer stem and host cells.
创新治疗策略:胃肠癌干细胞和宿主细胞的细胞重编程。
- 批准号:
23390199 - 财政年份:2011
- 资助金额:
$ 2.01万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Novel Innovative Safety Reprograming Technology by MicroRNAs
MicroRNA 创新的安全重编程技术
- 批准号:
23659617 - 财政年份:2011
- 资助金额:
$ 2.01万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Structural analysis of interface reactions in thin films by photoelectron diffraction
通过光电子衍射对薄膜界面反应进行结构分析
- 批准号:
09650886 - 财政年份:1997
- 资助金额:
$ 2.01万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Relationship between morphological change of nasomaxillary complex and nasal respiratory function following to maxillary protraction
上颌前伸后鼻上颌复合体形态变化与鼻呼吸功能的关系
- 批准号:
05454558 - 财政年份:1993
- 资助金额:
$ 2.01万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
網羅的なCpG siteのDNAメチル化の検索による肺腺癌のtumor suppressor geneの同定
综合寻找CpG位点DNA甲基化鉴定肺腺癌抑癌基因
- 批准号:
23K08296 - 财政年份:2023
- 资助金额:
$ 2.01万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Modeling Breast Cancer Associated with KMT2C as a Haploinsufficient and Recessive Tumor Suppressor Gene
与作为单倍体不足和隐性肿瘤抑制基因 KMT2C 相关的乳腺癌建模
- 批准号:
491638 - 财政年份:2023
- 资助金额:
$ 2.01万 - 项目类别:
Miscellaneous Programs
Enhancer RNA-mediated Tumor Suppressor Gene Expression in Normal and Malignant Hematopoiesis
正常和恶性造血过程中增强 RNA 介导的肿瘤抑制基因表达
- 批准号:
10755937 - 财政年份:2022
- 资助金额:
$ 2.01万 - 项目类别:
Comprehensive modeling of tumor suppressor gene-derived neoantigens in pancreatic cancer
胰腺癌中抑癌基因衍生的新抗原的综合建模
- 批准号:
10389366 - 财政年份:2022
- 资助金额:
$ 2.01万 - 项目类别:
SNF2 Histone Linker PHD RING Helicase as a novel tumor suppressor gene and risk factor in lung adenocarcinoma development
SNF2 组蛋白连接器 PHD RING 解旋酶作为新型抑癌基因和肺腺癌发展的危险因素
- 批准号:
472467 - 财政年份:2022
- 资助金额:
$ 2.01万 - 项目类别:
Operating Grants
Investigation of therapeutic targets in KRAS-mutant lung cancer cells co-existing multiple tumor suppressor gene mutations
共存多种抑癌基因突变的 KRAS 突变肺癌细胞治疗靶点的研究
- 批准号:
21K20793 - 财政年份:2021
- 资助金额:
$ 2.01万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Mechanism of neuroendocrine tumor suppression by the tumor suppressor gene PHLDA3
抑癌基因PHLDA3抑制神经内分泌肿瘤的机制
- 批准号:
20H03523 - 财政年份:2020
- 资助金额:
$ 2.01万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The Single Cell Biology of Context-Specific Responses to Loss of the RB Tumor Suppressor Gene
对 RB 肿瘤抑制基因丢失的特定反应的单细胞生物学
- 批准号:
419746 - 财政年份:2020
- 资助金额:
$ 2.01万 - 项目类别:
Operating Grants
3'UTR-dependent regulation of the PTEN tumor suppressor gene
PTEN 肿瘤抑制基因的 3UTR 依赖性调节
- 批准号:
10212969 - 财政年份:2020
- 资助金额:
$ 2.01万 - 项目类别:
Investigating Max as a tumor suppressor gene in small cell lung cancer and other neuroendocrine tumors
研究 Max 作为小细胞肺癌和其他神经内分泌肿瘤的抑癌基因
- 批准号:
10662195 - 财政年份:2020
- 资助金额:
$ 2.01万 - 项目类别: